Back to Authors

Jagavelu, Kumaravelu

https://orcid.org/0000-0002-9235-0600

Mayo Clinic

Mayo Clinic

Citations 2

Neuropilin-1 Stimulates Tumor Growth by Increasing Fibronectin Fibril Assembly in the Tumor Microenvironment
Yaqoob, Usman , Cao, Sheng , Shergill, Uday, Jagavelu, Kumaravelu , Geng, Zhimin , Yin, Meng , Assuncao, Thiago M. de , Cao, Ying , Szabolcs, Anna, Thorgeirsson, Snorri S., Yang, Ju , Roberts, Lewis R. , Shah, Vijay H. , Yaqoob, Usman , Schwartz, Martin A. , Ehman, Richard L. , Mukhopadhyay, Debabrata , Roberts, Lewis R , Yin, Meng

Cancer Research | June 27, 2012 | Volume: 72 | Issue: 16 | Pages: 4047-4059

10.1158/0008-5472.can-11-3907 Get It

Abstract The tumor microenvironment, including stromal myofibroblasts and associated matrix proteins, regulates cancer cell invasion and proliferation. Here, we report that neuropilin-1 (NRP-1) orchestrates communications between myofibroblasts and soluble fibronectin that promote α5β1 integrin–dependent fibronectin fibril assembly, matrix stiffness, and tumor growth. Tumor growth and fibronectin fibril assembly were reduced by genetic depletion or antibody neutralization of NRP-1 from stromal myofibroblasts in vivo. Mechanistically, the increase in fibronectin fibril assembly required glycosylation of serine 612 of the extracellular domain of NRP-1, an intact intracellular NRP-1 SEA domain, and intracellular associations between NRP-1, the scaffold protein GIPC, and the nonreceptor tyrosine kinase c-Abl that augmented α5β1 fibronectin fibril assembly activity. Analysis of human cancer specimens established an association between tumoral NRP-1 levels and clinical outcome. Our findings indicate that NRP-1 activates the tumor microenvironment, thereby promoting tumor growth. These results not only identify new molecular mechanisms of fibronectin fibril assembly but also have important implications for therapeutic targeting of the myofibroblast in the tumor microenvironment. Cancer Res; 72(16); 4047–59. ©2012 AACR.
Chemokine Receptor 7 Knockout Attenuates Atherosclerotic Plaque Development
Luchtefeld, Maren, Grothusen, Christina, Gagalick, Andreas, Jagavelu, Kumaravelu , Schuett, Harald , Tietge, Uwe J.F. , Pabst, Oliver , Grote, Karsten , Drexler, Helmut, Förster, Reinhold , Schieffer, Bernhard

Circulation | October 5, 2010 | Volume: 122 | Issue: 16 | Pages: 1621-1628

10.1161/circulationaha.110.956730 Get It

Background— Atherosclerosis is a systemic inflammatory disease characterized by the formation of atherosclerotic plaques. Both innate immunity and adaptive immunity contribute to atherogenesis, but the mode of interaction is poorly understood. Chemokine receptor 7 (CCR7) is critically involved in the transition from innate to adaptive immune activation by coordinating the migration to and positioning of antigen-presenting dendritic cells and T cells in secondary lymphoid organs. More recently, it was shown that CCR7 is also responsible for T-cell migration into inflamed tissues and T-cell egress from these tissues via the afferent lymph. Thus, we investigated the influence of a systemic CCR7 deficiency on atherogenesis in atherosclerosis-prone low-density lipoprotein receptor ( ldlr ) knockout mice. Methods and Results— CCR7 deficiency resulted in reduced atherosclerotic plaque development. CCR7 −/− T cells showed impaired entry and exit behavior from atherosclerotic lesions. Oxidized low-density lipoprotein, a key molecule for atherogenesis with antigenic features, was used to pulse dendritic cells and to expand T cells ex vivo. Adoptive transfer of C57BL/6 wild-type T cells but not ccr7 −/− -derived T cells primed with oxidized low-density lipoprotein–pulsed dendritic cells resulted in a reconstitution of atherogenesis in ccr7 −/− / ldlr −/− mice. Conclusion— These results demonstrate that both CCR7-dependent T-cell priming in secondary lymphoid organs and CCR7-dependent recirculation of T cells between secondary lymphoid organs and inflamed tissue are crucially involved in atherosclerotic plaque development.